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The glutamate system has received considerable attention in recent years as a target for development of novel 
therapeutics, including antidepressants. There are several lines of evidence showing the role of excitatory glutamatergic 
neurotransmission in depression and antidepressant activity of N-methyl D-aspartate (NMDA) antagonists like ketamine. 
The excitoxicity induced by glutamate receptor subtype NMDA is selectively and markedly inhibited by hesperidin. The 
hesperidin is one of the active constituents isolated from the roots of the cotton tree, Bombax ceiba L. (Bombacaceae). In 
this context, here, we studied the antidepressant activity of ethanolic extract of root of B. ceiba and its fractions viz., 
chloroform fraction CBCR (200 & 400 mg/kg); ethyl acetate fraction EABCR (200 & 400 mg/kg); n-butanol fraction 
(200 & 400 mg/kg) using two animal models of learned helplessness. To further elucidate the possible NMDA antagonist 
effect of hesperetin, an active metabolite of hesperedin, in silico docking studies were carried out using 5VIH protein of 
Rattus norvegicus (Brown rat) which consists of GluN1/GluN2A NMDA receptor agonist binding domains, using Inventus 
v 1.1. Results of in silico study revealed good binding affinity of hesperetin to 5VIH protein. The data indicated 
antidepressant like activity of the extract and its fractions. The effect was more promising with ethyl acetate and n-butanol 
fraction of the extract which could be attributed to the antagonistic effect of hesperetin to GluN1/GluN2A NMDA receptor, 
present in roots of B. ceiba. 
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Depression is a chronic mental disorder that causes 
changes in mood, thoughts, behaviour and physical 
health and leads to a decline in capacity to carry out 
even the simplest daily routine tasks
1
. Other than its 
chronic nature, symptoms associated with this mental 
disorder are often recurring and life threatening
2
. 
According to the World Health Organization (WHO) 
fact sheet 2021, depression is a common mental 
disorder and approximately more than 264 million 




The most important contributing factor for 
depression is exposure of day-to-day stressors in 
modern time. With the advancement of science, 
technology and economy, the nature of stress has 
changed markedly. Stressors interact to cause 
epigenetic changes altering gene expression, DNA 
structure and finally behaviour
4
. Moreover, stress 
induces activation of hypothalamic pituitary adrenal 
(HPA) axis, sympathetic hyperactivity along with brain 
processes of neuroplasticity and neurodegeneration
5
. 
Neurochemical, neurotransmitter and hormonal 
alterations after acute stress help body to face danger. 
However, a large number of evidences demonstrate 
that chronic stress is detrimental and can activate 
inflammatory pathways in brain and periphery
6
. Over-
activated immune system, increased sympathetic 
nervous system activity, and reduced glucocorticoid 
responsiveness all culminates at mediating 
inflammatory responses during stress
7
. Moreover, 
there is a crosstalk between excessive activation of 
inflammatory pathways and alterations in glutamate 
metabolism, and both are involved in development of 
mood disorders
7
. It is further supported by the finding 
that chronic inflammation in physically ill patients 
often develops symptoms of depression
7
. HPA axis 
activation and hypercortisolemia is often seen in 
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. There are several lines of 
evidences showing antidepressant like actions of  
N-methyl D-aspartate (NMDA) antagonists
9
. 
Ketamine, an NMDA antagonist induces rapid 
antidepressant effects that are in contrast to the 





Although there are many antidepressants mainly 
targeting the monoaminergic system, the major 
challenge in the treatment of this disease is that a 
significant portion of the patients taking 
antidepressants fail to attain full remission besides  
the lag period in effect and adverse side effects. 
Between 20-30% patients develop resistant in 
treatment of depression in which the patients fail to 
respond to the available drugs or other therapeutic 
approaches
13
. Thus, there is a strong unmet need to 
identify novel drug targets in order to develop 
effective next generation of treatments acting beyond 
monoaminergic system. Accumulating evidence 
suggests that the NMDA receptor, a subtype of 
glutamate receptors, plays an important role in the 
neurobiology and treatment of this disease and can be 
targeted with potential drug candidates. 
 
Bombax ceiba Linn. [Syn.: Bombax malabaricum 
DC.; Salmalia malabarica (DC.) Schott & Endl.; 
Gossampinus malbarica (DC) Merr.] commonly 
known as cotton tree or Malabar silk cotton tree, and 
locally shalmali, semal, simal and, shemal (Fam. 
Bombaceacea), is a tall deciduous tree distributed 
throughout Nepal, other part of tropical and 
subtropical Asia, Australia and Africa ascending the 
hills up to 1500 m height
14,15
. The roots of sapling up 
to about three-year-old are known as “semarkanda” 
and are used as a nerve tonic and as an astringent
16
. 
The plant posses stimulant, astringent, haemostatic, 
aphrodiasic, diuretic, emetic, demulcent, anti-
inflammatory, antidiarrhoeal, cardiotonic, anti-
dysenteric and antipyretic properties
17
.. Hesperidin is 
one of the major constituents present in B. ceiba 
root
18
. The excitotoxicity induced by the glutamate 
receptor (NMDA subtype) ligand was markedly 
inhibited by hesperidin in one of the study
19
.  
Since NMDA activation has role in pathophysiology 
of depression, here, we tried to evaluate 
antidepressant effect of different extracts of  
Bombax ceiba and study the NMDA antagonist 
effect of hesperetin (an active metabolite of 
hesperidin), through in silico study. 
Material and Methods 
 
Plant material 
Plant material was collected from local surrounding 
of Bauniya -6- Bauniya Kailali, Nepal; authenticated 
by, Dr IS Bisht, Principal Scientist, National Bureau 
of Plant Genetic Resources Regional Station, Niglat, 
Bhowali, District Nainital (Uttarakhand) (Specimen 
no. AO-01) and Senior Research officer Binod Kumar 
Basnet (183960) Department of Plant Resources, 
National Herbarium and Plant Laboratories, Godwari, 
Laiitpur, Nepal (Ref.No. 213-074-075). 
 
Extraction 
Roots of B. ceiba were shade dried and was 
coarsely powdered using a mixture grinder. The 
extraction of dried powdered material was carried out 
using ethanol (95%) as solvent in soxhlet apparatus. 
The ratio of solute (powdered plant material) to 
solvent (ethanol) used for extraction procedure was 
1:4. The ethanolic extracted content was concentrated 
using Rota Vap and coded as EBCR.  
The dried extract of B. ceiba root was further put 
into fractionation. The plant extract was dissolved in 
distilled water and partitioning was carried out using 
different solvents; chloroform, ethyl acetate and  
n-butanol with increasing polarity. The contents 
obtained after the partition were concentrated using 
Rota Vap and used for evaluation of activity. The 
chloroform fraction was coded as CBCR, ethyl 
acetate fraction was coded as EABCR and n-butanol 
fraction was coded as NBBCR. 
 
Animals 
Seven-week-old wistar albino rats procured from 
the animal house of Department of Pharmaceutical 
Sciences Bhimtal Campus, Uttarakhand, India were 
used in the study. The animals were housed in groups 
of 4 in home cage and had free access to standard 
animal feed and aqua water. They were maintained on 
12 h of light/dark cycle and ambient temperature of 
25±3°C. Animals were allowed to acclimatize to 
laboratory conditions 5 days before the experimentation. 
The experimental protocol was approved by the 
Institutional Animal Ethics Committee (IAEC 
approval no: KUDOPS/58) and conducted in 
accordance with internationally accepted principles 
for laboratory animal use and care.  
 
Experimental groups 
All animals were randomly allocated to different 
groups each group containing 6 animals. Each animal 
model contains 10 groups, four groups for lower  




dose (200 mg/kg), four for higher dose (400 mg/kg), 
one group for standard imipramine hydrochloride  
(15 mg/kg) and one for vehicle control. Group I 
received the vehicle (2% Tween 80 in distilled water) 
and served as negative control. Group II received the 
standard drug imipramine (15 mg/kg) and served as 
positive control. The test groups III-X, received two 
doses of ethanol extract and their solvent fractions, 
i.e. 200 and 400 mg/kg, respectively. The different 
doses of the extract, the solvent fractions and the 
standard drug were dissolved in 2% Tween 80 
solution immediately prior to use and administered 
orally for 7 days. Doses of the extract were selected 






Forced swim test (FST) 
The animals were treated daily for 1 week starting 
from day one, with the test drugs and standard drug. 
Wistar albino rats were forced to swim individually in 
a transparent glass container (20 cm in diameter and 
height of 50 cm) containing fresh water of 19 cm 
height, maintained at 25°C (±3°C). The activity was 
carried out in two session’s i.e. The first was a  
pre-testing session in which all untreated rats were 
allowed to swim in the container for 15 min each 
without any behavioural recording. This was done in 
order to check the fitness level of each animal and to 
obtain a stable immobility time profile
21
. In the 
second session (24 h after the pre-test), the rats were 
allowed to swim for 5 min and the total duration of 
immobility was recorded, one hour after the dosing. 
The rats were judged to be immobile when they 
remained floating without struggling, and making 
movements necessary only to keep their heads above 
the water. On the contrary, swimming was defined 
active escape or struggling movements such as head 
dipping, paddling with all four legs, circling the tank, 
and clambering at the walls. Fresh water was replaced 
after each rat. Following the sessions, each rat was 
dried on a towel and placed in a heater before it was 




Tail suspension test (TST) 
The TST is based on the fact that animals subjected 
to the short-term, inescapable stress are being 
suspended by their tail, develop an immobile posture. 
This protocol is conceptually related to the FST
24,25
. 
The animals were hanged at 50 cm above from 
ground using adhesive tape for period of 5 min and 
immobility time was noted. Adhesive tape was placed 
approximately 1cm from the tip of their tails. 
Treatment was given to animal for period of one week 
and on 7
th
 day the immobility time was again 
measured after 60 min of drug administration. The 
rats were judged to be immobile when they hanged 
motionless, making those movements necessary for 
respiration only. The duration of immobility was 





In order to rule out any false positive results in  
TST and FST, changes in motor activity of animals 
treated with the extract, their fractions and standard 
were measured automatically using actophotometer 
(Medicraft photoactometer INCO, model No: 600M-4D, 
S.No: PA-0129, India). The locomotor activity was 
recorded individually for 10 min. The locomotor 
activity of the individual animal was recorded at day 0 
(i.e. before administration of the test and standard). 
All the test drugs and standard drug were administered 
orally for seven days. At day 7, after 60 min of drug 
administration the final recording of locomotor 
activity was done. Apparatus was cleaned after each 
test session to prevent each rat from being influenced 






NovoDocker molecular docking, a computational 
procedure that predicts the non-covalent binding of 
macromolecules (receptor) and a small molecule 
(ligand), was used for docking studies. It is all-atom 
energy based Monte Carlo docking procedure
29
. The 
molecular docking of the active metabolite of 
hesperidin i.e hesperetin with the target protein 
(5VIH) was done using Inventus software. The 
various steps carried out in the docking of receptor 
with the target protein are as follows. 
 
Selection of protein 
The NMDA (ionotropic glutamate receptor) 
receptor plays an important role in depression. Stress 
cause excess release of the glutamate and activate 
NMDA receptor. Continuous activation of NMDA 
receptor leads to excitotoxicity leading to neuronal 
apoptosis or necrosis leading to depression
30
. In order 
to prevent neuronal apoptosis or necrosis it is 
necessary to prevent the binding of glutamate to 
NMDA receptors. On the basis of this, 5VIH was 
selected as the target protein which is a Rattus 
norvegicus (Brown rat) protein. The protein consists 
of GluN1/GluN2A NMDA receptor agonist binding 
domains with glycine and antagonist 4-flurophenyl-
ACEPC ((S)-5-[(R)-2-amino-2-carboxyethyl]-4,5-




dihydro-1H-pyrazole-3-carboxylic acid). Thus selected 
protein 5VIH was downloaded from the Research 
Collaboratory for Structural Bioinformatics Protein 
Databank (RCSB PDB), and was converted into PDB 
format. The protein consisted of two chains A and B 
with agonist glycine bound to chain A and antagonist 
4-flurophenyl-ACEPC bound to chain B
31
. The 
glycine and antagonist bound to protein were 
removed.  
 
Selection of the ligand 
Hesperidin is reported to be present in root of 
Bombax ceiba
19
 and its aglycone hesperetin has many 
beneficial therapeutic effects including potent 
antiinflammatory and neuroprotective effect
32
. The 
excitotoxicity induced by the glutamate receptor 
(NMDA subtype) ligand was markedly inhibited by 
hesperidin in one of the study
19
. Hesperidin is 
absorbed in the form of its aglycone, hesperetin, after 
removal of disaccharide by intestinal bacteria
33
. On 
the basis of above evidence the hesperetin was 
selected as a ligand. The hesperetin was downloaded 
and was converted into 3D form and finally hydrogen 
atoms were merged to the target receptor molecule. 
 
Energy minimization and clash optimization 
The crystalline protein 5VIH was stabilized by 
energy minimization. The protein attains the least 
energy level and become established. Many a times, 
energy minimization is unable to remove all stearic 
clashes from proteins structure which may create 
anomaly in outcome, during docking of protein and 
ligand/inhibitor. In order to prevent such anomaly, 
clash optimization of protein was done. This 
application based on monte carlo technique is used to 





In silico molecular docking is an automated and 
sophisticated computation structure based drug design 
method to study the interaction of ligand and a 
receptor. It determines how a ligand may bind to the 
active site cleft of a protein to produce energetically 
stable geometry of ligand receptor complex. Flexible 
ligands can rotate by its rotable bond in many 
different orientations and conformation in the active 
site, and then computes a score for each complex. The 
interaction energy is represented by dock score. This 
score is used to predict the binding affinity of a ligand 
towards receptor
34,35
. Some programs store the data 
for all of the tested orientation but most only keep a 
number of those with the best score
36
. The  
4-flurophenyl-ACEPC is an antagonist binding with 
the NMDA 2A ionotropic glutamate receptor. 
Similarly, to find out the antagonistic effect of the 
hesperetin on 5VIH protein; the antagonist 4-
flurophenyl-ACEPC was removed from its binding 
site (chain B) and hesperetin was docked instead. 
 
Statistical analysis 
The data obtained from the experiment was 
evaluated using Graph Pad Prism 5 using One-way 
Analysis of Variance (ANOVA) followed by 
Turkey’s post-hoc analysis. All the results observed 
from the experiment were expressed as mean ± S.E.M 
and level of significance was set at P <0.05. 
 
Results and Discussion 
 
Locomotor activity 
As shown in Fig. 1, administration of different 
doses (200 and 400 mg/kg) of ethanolic extract and its 
fraction showed no statistical difference in locomotor 
activity as compared to that of the respective control 
and standard both a day 0 and 7. 
 
Forced swim test 
The behavioural effects produced in the FST test 
owing to drug administration are presented in Fig. 2A. 
A significant reduction in immobility time was 
observed in the rats when treated continuously for one 
week with different doses of crude ethanolic extract, 
chloroform fraction, ethyl acetate fraction and  
n-butanol fraction of B. ceiba roots as compared  
to vehicle control. Both the doses of ethyl acetate  
 
 
Fig. 1 — Effect of ethanolic extract and its fraction (chloroform, 
ethylacetate and n-butanol) on locomotor activity. [Each column 
represent the mean±SEM (n=6). The one-way ANOVA followed 
by Tukey’s test was performed on raw data. Veh: Vehicle; EBCR: 
Ethanolic extract of root, CBCR: Chloroform fraction of root, 
EABCR: ethyl acetate fraction, NBBCR: n-butanol fraction;  
IMP: imipramine] 
 




and n-butanol fraction produced most significant 
antidepressant like action than ethanol extract and 
choloroform fraction. Standard drug treatment with 
imipramine also resulted in significant decrease in 
immobility period as compared to vehicle treated 
group and the effect is comparable to ethyl acetate 
and n-butanol fraction.  
 
Tail suspension test 
Both 200 and 400 mg/kg doses of crude ethanolic 
extract, chloroform fraction, ethyl acetate fraction and 
n-butanol fraction of B. ceiba roots significantly 
decreased immobility period in TST as compared  
to vehicle control on day 7. Both ethyl acetate  
and n-butanol fraction were found to be more 
effective than ethanol extract and choloroform 
fraction. A significant reduction in immobility time 
was also observed in the rats treated with standard 
drug impiramine as compared to vehicle control  
(P <0.05). The effects produced by ethyl acetate and 
n-butanol fraction were found to be comparable with 
impiramine Fig. 2B. 
 
 
Fig. 3 — Interaction between 5VIH (NMDA recptor) and hesperitin 
 
Table 1 — The docking scores of different poses of Hesperetin 
Poses number Bio-affinity 
First 5.46 kcal/mol 
Second 6.47 kcal/mol 
Third 5.07 kcal/mol 
Fourth 6.46 kcal/mol 
Fifth 6.35 kcal/mol 
Sixth 6.35 kcal/mol 
Seventh 6.00 kcal/mol 
Eight 6.44 kcal/mol 
 
Docking result 
After docking of the ligand (hesperetin) with 
protein, eight possible poses were obtained (Fig. 3). 
Then binding affinity of each pose was calculated. 
Among eight poses the bio-affinity of all was  
found above 5 and the second pose was found  
as best binding pose with highest binding affinity 
(6.47 kcal/mol) (Table 1).  
 
Depression is a most common life threatening 
illness that takes away person’s ability to carry out 
their daily activity. There are lots of drugs in market 
that act through various mechanisms which involve 
serotonergic, noradrenergic and dopaminergic system. 
However, heterogeneous clinical response to anti-
depressants and susceptibility to adverse effect are major 
clinical problems. Therefore there is an urgent need for 
effective antidepressant drugs in the market for complete 
remission. In the present study, we demonstrated 
significant antidepressant effect of B. ceiba root extract 
in two animal models of depression viz., FST and TST. 
The immobility time recorded in these models reflect 
despair behavior or failure to adapt to stress
37,38
. 
Antidepressant can be distinguished from stimulant 





The results obtained from present study shows that 
the ethanolic extract and its fraction posses 
 
 
Fig. 2 — Effect of ethanolic extract and its fraction (chloroform, 
ethylacetate and n-butanol) on (A) Forced swim test; and (B) Tail 
suspension test. [Each column represent the mean±SEM (n=6). 
The one-way ANOVA followed by Tukey’s test was performed 
on raw data. *P <0.05 vs. control, #P <0.05 vs. EABCR 1,  
$ P <0.05 vs. EABCR 2, % P <0.05 vs. NBBCR 1, &P <0.05 vs. 
NBBCR 2. Veh: Vehicle; EBCR: Ethanolic extract of root, 
CBCR: Chloroform fraction of root, EABCR: Ethyl acetate 
fraction, NBBCR: n-Butanol fraction; IMP: Imipramine] 
 




antidepressant like effect evident by significant 
reduction in the immobility time in FST and TST. 
Neither ethanolic extract nor its fractions altered 
motor activity, thus showing that increased motor 
activity is not associated with antidepressant effect. 
Likewise positive control did not alter locomotor 
activity. In both the models of depression, the activity 
of the ethyl acetate fraction (EABCR) and n-butanol 
fraction were found to be superior to that of the 
chloroform fraction (CBCR)  
 
Hesperedin principally an antioxidant and  
anti-inflammatory bioflavonoid is present in the  
root of B. ceiba
9
. It is absorbed in the form of its 
aglycone, hesperetin, after removal of disaccharide  
by intestinal bacteria and is metabolized in the 
intestinal epithelium and liver
33
. Glucuronides and 
sulfoglucouronides of the hesperetin are the major 
conjugates derived from hesperidin in rat plasma, and 
they reach a peak level between 4 and 6 h
39
. 
Hesperedin has many therapeutic effect including 
hypolipedemic, antimicrobial, anticancer, antiulcer, 
antihypertensive, anticarcinogenic effect and similarly 
its aglycone, hesperetin has many benificial effect 
such as antioxidant, antiinflamatory, neuroprotetive, 
antiviral and cholestrol lowering effect
19,40-43
. The 
excitoxicity induced by the glutamate receptor 





A functional NMDA-glutamatergic receptor 
comprises of heterotetramer complex with at least two 
obligatory GluN1 subunits and two regionally 
localized variables GluN2(A-D) subunits. The 
GluN1/GluN2B TM segments are considered to be 
the part of the receptor that forms the binding pockets 
for uncompetitive NMDA receptor antagonists
44
. The 
activation of the NMDA receptor requires two 
agonists, glycine and two molecules of agonist 
glutamate
45
. The glycine and glutamate bind to the 
respective region on GluN1 and GluN2 subunit, 
respectively before the channel gets activated. 
Binding of the glycine and glutamate on NMDA 
receptor selectively opens cationic ion channels and 
significant amount of Ca
2+
 enters inside neuron. 
Continuous activation of large numbers of NMDA 
receptors leads to increases in intracellular calcium 
loads and catabolic enzyme (DNAses, proteases, 
phosphatases and phospholipases) activities triggering 
a cascade of events finally leading to apoptosis or 
necrosis
30
. Stress causes excess release of glutamate 
in experimental animal models and thus glutamate 
excitotoxicity. Antidepressants were found to inhibit 
stress induced presynaptic release of glutamate in 
these models. Several studies report elevated 
concentrations of glutamate in plasma and increased 





On the basis of docking result obtained from the 
CADD, the binding affinity of the hesperetin to 
protein 5VIH (Crystal structure of GluN1/GluN2A 
NMDA receptor agonist binding domains with 
glycine and antagonist, 4-fluorophenyl-ACEPC) was 
found to be higher than that of 5 kcal/mol. It means 
that the molecule has good binding affinity with 
GluN1/GluN2A NMDA receptor and shows 
antagonistic effect. As a result, inhibition of the 
NMDA receptor by hesperetin might have prevented 
the excitotoxicity of neuronal cell thus exhibiting 
antidepressant like effect. In order to find out 
whether the hesperetin act on GluN1/GluN2A 
NMDA receptor inside our body it is necessary to 




The preliminary investigation on the ethyl acetate 
and n-Butanol fraction of Bombax ceiba root extract 
showed highest antidepressant activity in both the 
animal models without having any effect on 
locomotor activity. The effect was found to be 
comparable with the standard drug imipramine, thus 
suggesting B. ceiba as a potential nutraceutical for 
antidepressant effect. The in silico docking study 
revealed NMDA antagonistic activity of hesperetin 
which is an active metabolite of hesperdin. Further, 
phytochemical studies could be extended in future to 
quantify the amount of hesperidin in each fraction 
along with mechanistic studies to elucidate the role 
of gluatmate system and to correlate in silico results 
well with in vivo results.  
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